Obtained results confirm that a combination of biomarkers selected produces better results for Stage I & Stage II detection than CA-62 cancer marker alone (AUC 0.990 vs 0.973) and other previously proposed panel of markers containing PENK, pro-SP, hGH and CA15-3 (AUC = 0.785) (17). Here, PENK is linked to cancer.